Some 850 lung cancer centers of excellence are helping pinpoint nodule-management best practices and offering guidance to providers without programs in place.
The Medical Imaging Drugs Advisory Committee reviews data on radiopharmaceuticals and contrast media, recommending best practices to the agency's commissioner.
The data will draw on everything from census findings to driving habits gathered from vehicle sensors to—arguably most consequentially—medical records.